Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Franziska Guenther

Postdoctoral Research Scientist

I joined the Oxford Drug Discovery Institute in collaboration with the Wade-Martins’ lab in 2018 as a Postdoctoral Research Scientist. My research targets the Ubiquitination pathway in Parkinson’s Disease (PD) and currently I am using biochemical and biophysical approaches to investigate and identify potential new selective deubiquitinating enzyme inhibitor compounds as a therapeutically treatment of PD.

I gained my scientific background in Molecular Cell Biology and Molecular Medicine at the University of Erlangen-Nuremberg, where I obtained my B.Sc. and M.Sc. degree and then completed a PhD in Neurophysiology in collaboration with King`s College London.

For my doctoral studies, I investigated sensory transduction mechanisms and their importance for nociception and pain on TRP channels. In particular, I investigated the role of the ion-channel TRPA1 in diabetic neuropathy as well as targeting TRPA1 for drug discovery using a wide range of techniques including patch clamp electrophysiology and Ca2+ imaging.

Recent publications

More publications